Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus

Clinical trial NCT00231387 · COMPLETED

Trial details

NCT number: NCT00231387
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-insulin-dependent Diabetes Mellitus

Start date: 2002-09-01
Primary completion: 2005-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.